Zarski Jean-Pierre
Clinique universitaire d'hepato-gastroentérologie, CRI Inserm/UJF U823 IAPC, Institut Albert-Bonniot, CHU de Grenoble, 38043 Grenoble Cedex.
Rev Prat. 2011 Jan;61(1):33-8.
Acute hepatitis B is associated with a risk of evolution to chronic hepatitis in 90% of cases in the newborn, 50% in the childhood and 5 to 10% in adults. During the chronic phase, we usually distinguish 4 phases: the immunotolerance phase with a positive HBe antigen, ALT in the normal value, high viral load and the absence of necro-inflammation; then the phase of immune clearance associated with fluctuations of the viral load and ALT level, HBe antigen seroconversion and histological lesions of chronic hepatitis; at this phase, we distinguish the HBe antigen positive chronic hepatitis B and the HBe antigen negative chronic hepatitis B, called "mutant virus" which is the main chronic hepatitis 8 observed in France. The treatment is usually discussed during this chronic hepatitis phase. The third phase is called inactive chronic carriage and is associated with no detectable viral replication, normal ALT and the absence of necro-inflammation. A fourth phase is possible with viral reactivation episods. Hepatitis C leads to chronic hepatitis in 2/3 to 3/4 of cases. Factors associated to the progression of the disease are the age of patient at the time of contamination, the male gender, alcohol consumption, HIV co-infection and metabolic factors, especially steatosis. These factors increase the risk of progression of the disease and the evolution to cirrhosis and hepatocellular carcinoma.
急性乙型肝炎在新生儿中有90%的病例有发展为慢性肝炎的风险,儿童中有50%,成人中有5%至10%。在慢性期,通常分为4个阶段:免疫耐受期,HBe抗原阳性,ALT值正常,病毒载量高且无坏死性炎症;然后是免疫清除期,与病毒载量和ALT水平波动、HBe抗原血清学转换及慢性肝炎组织学病变相关;在此阶段,区分HBe抗原阳性慢性乙型肝炎和HBe抗原阴性慢性乙型肝炎,后者称为“变异病毒”,是法国观察到的主要慢性乙型肝炎。通常在慢性肝炎阶段讨论治疗问题。第三阶段称为非活动性慢性携带,与无法检测到病毒复制、ALT正常及无坏死性炎症相关。第四阶段可能出现病毒再激活发作。丙型肝炎在2/3至3/4的病例中会导致慢性肝炎。与疾病进展相关的因素包括感染时患者的年龄、男性性别、饮酒、HIV合并感染及代谢因素,尤其是脂肪变性。这些因素会增加疾病进展以及发展为肝硬化和肝细胞癌的风险。